Company / Working Capital
KIORA PHARMACEUTICALS INC Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$18.1M
FY2025
5-year range
-$46.1K / $23.7M
FY2021-FY2025
Trend
-23.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 8 years, ranging from -$6M in FY2017 to $24M in FY2024.
Based on SEC 10-K filings.
$18M in FY2025 with a 5-year CAGR of +243.6%.
Improved from -$46,106 to $18M over the past 4 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +243.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +243.6%, indicating consistent growth.
- In FY2025, working capital decreased 23.5% year-over-year.
- Peak working capital was recorded in FY2024.
- Lowest working capital in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.1M | -23.5% |
| FY2024 | $23.7M | +51497.4% |
| FY2021 | -$46.1K | -221.9% |
| FY2020 | $37.8K | -98.7% |
| FY2019 | $2.9M | -36.9% |
| FY2018 | $4.6M | +172.4% |
| FY2017 | -$6.4M | -102.1% |
| FY2016 | -$3.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026